Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate

OBJECTIVE: Hydroxychloroquine (HCQ) use for the treatment of dermatomyositis (DM) has been associated with adverse cutaneous reactions. We applied a new user, active comparator, retrospective design to assess differences in adverse cutaneous reactions or hospitalizations between HCQ and methotrexate...

Descripción completa

Detalles Bibliográficos
Autores principales: Allenzara, Astia, Hollis, Alison, Álvarez, Carolina, Lovelace, Haejin, Maczuga, Steve, Helm, Matthew, Olsen, Nancy, Nelson, Amanda, Foulke, Galen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642252/
https://www.ncbi.nlm.nih.gov/pubmed/37743678
http://dx.doi.org/10.1002/acr2.11605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642252/
https://www.ncbi.nlm.nih.gov/pubmed/37743678
http://dx.doi.org/10.1002/acr2.11605

Ejemplares similares